141 related articles for article (PubMed ID: 37356621)
1. Dual deletion of guanylyl cyclase-A and p38 mitogen-activated protein kinase in podocytes with aldosterone administration causes glomerular intra-capillary thrombi.
Sugioka S; Yamada H; Ishii A; Kato Y; Yamada R; Mori KP; Ohno S; Handa T; Ikushima A; Ishimura T; Osaki K; Tokudome T; Matsusaka T; Nebreda AR; Yanagita M; Yokoi H
Kidney Int; 2023 Sep; 104(3):508-525. PubMed ID: 37356621
[TBL] [Abstract][Full Text] [Related]
2. Natriuretic peptide receptor guanylyl cyclase-A pathway counteracts glomerular injury evoked by aldosterone through p38 mitogen-activated protein kinase inhibition.
Kato Y; Mori K; Kasahara M; Osaki K; Ishii A; Mori KP; Toda N; Ohno S; Kuwabara T; Tokudome T; Kishimoto I; Saleem MA; Matsusaka T; Nakao K; Mukoyama M; Yanagita M; Yokoi H
Sci Rep; 2017 Apr; 7():46624. PubMed ID: 28429785
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury.
Ogawa Y; Mukoyama M; Yokoi H; Kasahara M; Mori K; Kato Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Tokudome T; Kishimoto I; Sugawara A; Nakao K
J Am Soc Nephrol; 2012 Jul; 23(7):1198-209. PubMed ID: 22652704
[TBL] [Abstract][Full Text] [Related]
4. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
[TBL] [Abstract][Full Text] [Related]
5. Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.
Handa T; Mori KP; Ishii A; Ohno S; Kanai Y; Watanabe-Takano H; Yasoda A; Kuwabara T; Takahashi N; Mochizuki N; Mukoyama M; Yanagita M; Yokoi H
Sci Rep; 2021 Nov; 11(1):21835. PubMed ID: 34750411
[TBL] [Abstract][Full Text] [Related]
6. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK.
Yoshida S; Nagase M; Shibata S; Fujita T
Nephron Exp Nephrol; 2008; 108(3):e57-68. PubMed ID: 18391505
[TBL] [Abstract][Full Text] [Related]
7. Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.
Kobayashi N; Ueno T; Ohashi K; Yamashita H; Takahashi Y; Sakamoto K; Manabe S; Hara S; Takashima Y; Dan T; Pastan I; Miyata T; Kurihara H; Matsusaka T; Reiser J; Nagata M
Am J Physiol Renal Physiol; 2015 Mar; 308(6):F614-26. PubMed ID: 25587125
[TBL] [Abstract][Full Text] [Related]
8. A plasminogen activator inhibitor type 1 mutant retards diabetic nephropathy in db/db mice by protecting podocytes.
Zhang J; Gu C; Lawrence DA; Cheung AK; Huang Y
Exp Physiol; 2014 May; 99(5):802-15. PubMed ID: 24443353
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury.
Pengal R; Guess AJ; Agrawal S; Manley J; Ransom RF; Mourey RJ; Benndorf R; Smoyer WE
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F509-19. PubMed ID: 21613416
[TBL] [Abstract][Full Text] [Related]
10. Glomerular VEGF resistance induced by PKCδ/SHP-1 activation and contribution to diabetic nephropathy.
Mima A; Kitada M; Geraldes P; Li Q; Matsumoto M; Mizutani K; Qi W; Li C; Leitges M; Rask-Madsen C; King GL
FASEB J; 2012 Jul; 26(7):2963-74. PubMed ID: 22499584
[TBL] [Abstract][Full Text] [Related]
11. Dopamine 1 receptor activation protects mouse diabetic podocytes injury via regulating the PKA/NOX-5/p38 MAPK axis.
Shao X; Zhang X; Hu J; Gao T; Chen J; Xu C; Wei C
Exp Cell Res; 2020 Mar; 388(2):111849. PubMed ID: 31954110
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-beta1 and JNK signaling in capillary tube patterning.
Bein K; Odell-Fiddler ET; Drinane M
Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1012-22. PubMed ID: 15201140
[TBL] [Abstract][Full Text] [Related]
13. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
14. A novel podocyte protein, R3h domain containing-like, inhibits TGF-β-induced p38 MAPK and regulates the structure of podocytes and glomerular basement membrane.
Ishikawa T; Takemoto M; Akimoto Y; Takada-Watanabe A; Yan K; Sakamoto K; Maezawa Y; Suguro M; He L; Tryggvason K; Betsholtz C; Yokote K
J Mol Med (Berl); 2021 Jun; 99(6):859-876. PubMed ID: 33620517
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury.
Bai M; Chen Y; Zhao M; Zhang Y; He JC; Huang S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F556-F564. PubMed ID: 28052869
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury.
Su M; Dhoopun AR; Yuan Y; Huang S; Zhu C; Ding G; Liu B; Yang T; Zhang A
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F520-31. PubMed ID: 23761667
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic Peptide Receptor Guanylyl Cyclase-A in Podocytes is Renoprotective but Dispensable for Physiologic Renal Function.
Staffel J; Valletta D; Federlein A; Ehm K; Volkmann R; Füchsl AM; Witzgall R; Kuhn M; Schweda F
J Am Soc Nephrol; 2017 Jan; 28(1):260-277. PubMed ID: 27153922
[TBL] [Abstract][Full Text] [Related]
18. Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts.
Liu RM; Choi J; Wu JH; Gaston Pravia KA; Lewis KM; Brand JD; Mochel NS; Krzywanski DM; Lambeth JD; Hagood JS; Forman HJ; Thannickal VJ; Postlethwait EM
J Biol Chem; 2010 May; 285(21):16239-47. PubMed ID: 20228065
[TBL] [Abstract][Full Text] [Related]
19. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.
Abdallah MS; Kennedy CRJ; Stephan JS; Khalil PA; Mroueh M; Eid AA; Faour WH
Inflamm Res; 2018 Feb; 67(2):191-201. PubMed ID: 29085960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
